IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,027,750 | +350.7% | 1,225,000 | +122.7% | 2.74% | +369.7% |
| Q2 2023 | $10,433,500 | +146850.7% | 550,000 | +37.5% | 0.58% | +22.9% |
| Q4 2022 | $7,100 | -99.9% | 400,000 | +18.7% | 0.48% | +295.8% |
| Q1 2021 | $5,406,000 | -92.5% | 337,048 | -78.4% | 0.12% | -93.0% |
| Q4 2020 | $72,193,000 | +25.3% | 1,562,952 | -4.6% | 1.72% | -22.5% |
| Q3 2020 | $57,639,000 | – | 1,637,951 | – | 2.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |